Advanced search
Publication Cover
Acta Cardiologica Volume 79, 2024 - Issue 4
Submit an article Journal homepage
27
Views
1
CrossRef citations to date
0
Altmetric
Viewpoint

Use of percutaneous ventricular assist device as bridge to high risk combined heart valve surgery

Philippe Amabilia Department of Anesthesiology, University Hospital Center, Liege, BelgiumCorrespondence[email protected]
,
Gauthier Debrouxa Department of Anesthesiology, University Hospital Center, Liege, Belgium
,
Patrizio Lancellottib Department of Cardiology, University Hospital Center, Liege, Belgium
,
Grégory Hansa Department of Anesthesiology, University Hospital Center, Liege, Belgium
,
Vincent Bonhommea Department of Anesthesiology, University Hospital Center, Liege, Belgium
&
Vincent Tchana-Satoc Department of Cardiovascular and Thoracic Surgery, University Hospital Center, Liege, Belgium
Pages 501-506 | Received 06 Mar 2024, Accepted 18 Mar 2024, Published online: 08 Apr 2024

References

  • Lorusso R, Gelsomino S, De Cicco G, et al. Mitral valve surgery in emergency for severe acute regurgitation: analysis of postoperative results from a multicentre study. Eur J Cardiothorac Surg. 2008;33(4):573–582. doi: 10.1016/j.ejcts.2007.12.050.
  • McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368.
  • Dekker ALAJ, Reesink KD, van der Veen FH, et al. Intra-aortic balloon pumping in acute mitral regurgitation reduces aortic impedance and regurgitant fraction. Shock. 2003;19(4):334–338. doi: 10.1097/00024382-200304000-00007.
  • Ergle K, Parto P, Krim SR. Percutaneous ventricular assist devices: a novel approach in the management of ­patients with acute cardiogenic shock. Ochsner J. 2016;16(3):243–249.
  • Chera HH, Nagar M, Chang N-L, et al. Overview of ­impella and mechanical devices in cardiogenic shock. Expert Rev Med Devices. 2018;15(4):293–299. doi: 10.1080/17434440.2018.1456334.
  • Maniuc O, Salinger T, Anders F, et al. Impella CP use in patients with non-ischaemic cardiogenic shock. ESC Heart Fail. 2019;6(4):863–866. doi: 10.1002/ehf2.12446.
  • Lemaire A, Anderson MB, Lee LY, et al. The impella ­device for acute mechanical circulatory support in ­patients in cardiogenic shock. Ann Thorac Surg. 2014;97(1):133–138. doi: 10.1016/j.athoracsur.2013.07.053.
  • Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
  • Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2021;43(7):561–632.
  • Watanabe S, Fish K, Kovacic JC, et al. Left ventricular unloading using an impella CP improves coronary flow and infarct zone perfusion in ischemic heart failure. J Am Heart Assoc. 2018;7:1–11.
  • Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012;125(2):289–297. doi: 10.1161/CIRCULATIONAHA.111.051540.
  • Markus B, Patsalis N, Chatzis G, et al. Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2020;9(2):158–163. doi: 10.1177/2048872619860218.
  • Osswald A, Schmack B, Goldwasser R, et al. Impella 5.0® as bridge-to-recovery short-term mechanical circulatory support after LVAD explantation. J Thorac Dis. 2019;11(Suppl 6):S960–S962. doi: 10.21037/jtd.2019.04.34.
  • Imaoka S, Kainuma S, Toda K, et al. Impella support as a bridge to surgery for severe mitral regurgitation with cardiogenic shock. Circ Rep. 2021;3(3):178–181. doi: 10.1253/circrep.CR-21-0016.
  • Lorusso R, Whitman G, Milojevic M, et al. 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients. Eur J Cardio-Thoracic Surg. 2020;59:12–53.
  • Belohlavek J, Hunziker P, Donker DW. Left ventricular unloading and the role of ECpella. Eur Heart J Suppl. 2021;23(Suppl A):A27–A34. doi: 10.1093/eurheartj/suab006.
  • Donker DW, Brodie D, Henriques JPS, et al. Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions. Perfus. 2019;34(2):98–105. doi: 10.1177/0267659118794112.
  • Baldetti L, Gramegna M, Beneduce A, et al. Strategies of left ventricular unloading during VA-ECMO support: a network meta-analysis. Int J Cardiol. 2020;312:16–21. doi: 10.1016/j.ijcard.2020.02.004.
  • Tongers J, Sieweke JT, Kühn C, et al. Early escalation of mechanical circulatory support stabilizes and potentially rescues patients in refractory cardiogenic shock. Circ Hear Fail. 2020;13(3):e005853.
  • Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19(3):404–412. doi: 10.1002/ejhf.668.
  • Pingpoh C, Salama A, Diab N, et al. Postcardiotomy mechanical support in patients with mitral valve prostheses is associated with poor survival. Int J Artif Organs. 2020;45(2):127–133. doi: 10.1177/0391398820982621.
  • Benito-González T, Estevez-Loureiro R, Garrote-Coloma C, et al. Combined transcatheter treatment of ventricular septal rupture and mitral regurgitation after an acute myocardial infarction. JACC Cardiovasc Interv. 2017;10(24):2577–2579. doi: 10.1016/j.jcin.2017.08.048.
  • Valle JA, Miyasaka RL, Carroll JD. Acute mitral regurgitation secondary to papillary muscle tear: is transcatheter edge-to-edge mitral valve repair a new paradigm? Circ Cardiovasc Interv. 2017;10:1–7.
  • Komatsu I, Cohen EA, Cohen GN, et al. Transcatheter mitral valve edge-to- edge repair with the new MitraClip XTR system for acute mitral regurgitation caused by papillary muscle rupture. Can J Cardiol. 2019;35(11):1604.e5–1604.e7. doi: 10.1016/j.cjca.2019.06.024.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.